VISTA in hematological malignancies: a review of the literature

VISTA in hematological malignancies: a review of the literature

In recent years, tumor immunotherapy has become an active research area, with the emergence of immune checkpoint inhibitors (ICIs) revolutionizing immunotherapy. Clinical evidence indicates that programmed cell death protein 1 (PD-1) monoclonal antibodies and other drugs have remarkable therapeutic...

Full description

Bibliographic Details
Main Authors: Yuanjia Duan, Xiaotong Ren, Xinyu Guo, Jiayi Xie, Zhaoyun Liu, Lijuan Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint receptors
VISTA
hematological malignancies
tumor microenvironment
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1466839/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1466839/full

Similar Items